Activist Investor Jeff Smith is Buying These 15 SPACs in 2022
In this article, we will look at the 15 SPACs activist investor Jeff Smith is buying in 2022.
Bioplus Acquisition Corp. (BIOS)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Financial Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 0 | $0 | 0% | ||
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Walleye Capital Will England | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is BioScrip Inc. (BIOS) Relatively A Good Stock To Buy?
We hate to say this but, we told you so.
Option Care Health, Inc. (BIOS): Are Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Option Care Health, Inc. (BIOS) A Good Stock To Buy?
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Is BioScrip Inc. (BIOS) A Good Stock To Buy?
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Here's What Hedge Funds Think About BioScrip Inc. (BIOS)
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31.
Here is What Hedge Funds Think About BioScrip Inc. (BIOS)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...
Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now
There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals that also pay substantial dividends, to small...
13G Filing: Ardsley Partners and Bioscrip Inc. (BIOS)
Bioscrip Inc. (NASDAQ:BIOS): Philip Hempleman's Ardsley Partners filed an amended 13D.
You can check out Ardsley Partners' latest holdings and filings here.
13G Filing: Venor Capital Management and Bioscrip Inc. (BIOS)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
Hedge Fund Resource Center Billionaire Hedge Funds
